-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GNv+MTGacHJp/h37JTa2ocb3Bw0JsuXuw26GsfJsSd7IcDBo+AA3O8PZbk/Xlpzj W9GMX6AsRIT5gIAo7Fas5w== 0001231919-04-000237.txt : 20041122 0001231919-04-000237.hdr.sgml : 20041122 20041122163055 ACCESSION NUMBER: 0001231919-04-000237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041118 FILED AS OF DATE: 20041122 DATE AS OF CHANGE: 20041122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAVANAUGH JAMES H CENTRAL INDEX KEY: 0001013473 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 041161082 BUSINESS ADDRESS: BUSINESS PHONE: 6094303930 MAIL ADDRESS: STREET 1: 44 NASSAU ST CITY: PRINCETON STATE: NJ ZIP: 08542 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-11-18 0000936402 SHIRE PHARMACEUTICALS GROUP PLC SHPGY 0001013473 CAVANAUGH JAMES H 44 NASSAU STREET PRINCETON NJ 08542 1 0 0 0 Ordinary Shares, nominal value 5p 2004-11-18 4 S 0 10000 29.95 D 386555 D 10,000 American Depository Shares ("ADS") were sold by HealthCare Ventures V, L.P. ("HCVV"), the owner of the securities. Each ADS is convertible into 3 Ordinary Shares, nominal value 5p. Mr. Cavanaugh is a general partner of HealthCare Partners V, L.P. ("HCPV"), the general partner of HCVV and as such may be deemed to beneficially own those shares owned by HCVV. Mr. Cavanaugh disclaims beneficial ownership of the shares owned by HCVV except to the extent of his pecuniary interest and this report shall not be deemed an admission that he is the beneficial owner of the 10,000 ADS for purposes of Section 16. Jeffrey Steinberg, Attorney-in-Fact 2004-11-22 -----END PRIVACY-ENHANCED MESSAGE-----